RCUS in the 13F filings
Arcus Biosciences Inc · CUSIP 03969F109
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 26
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 4 listed it in both
- Shares listed
- 20,268,119
- combined, among listed positions
- Reported value
- $483m
- combined, at the quarter end
Among the 92 comparable managers: 12 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,041,464.
Managers listing RCUS in Q4 2025
26 of 26 holders
Largest increases and reductions, by shares
Increases
- Wellington Management Group LLPexisting position · 5,184,509 shares now+3,918,220
- Marshall Wace LLPnew position · 3,387,794 shares now+3,387,794
- Balyasny Asset Management LLCexisting position · 815,561 shares now+715,188
- Tudor Investment Corpnew position · 208,639 shares now+208,639
- Invesco Ltdexisting position · 414,365 shares now+121,961
Reductions
- Fidelity (FMR LLC)existing position · 1,135,178 shares now-1,160,843
- Point72 Asset Management LPexisting position · 3,280,000 shares now-1,052,479
- Millennium Management LLCexisting position · 168,876 shares now-466,068
- Two Sigma Investments LPexisting position · 139,631 shares now-331,891
- Citadel Advisors LLCexisting position · 104,701 shares now-190,353
New positions and exits
New (3)
Exited (5)
- Two Sigma Advisers LPwas $3.9m
- Arrowstreet Capital LPwas $3.3m
- Man Group PLCwas $1.0m
- Brevan Howard Capital Management LPwas $573k
- Acadian Asset Management LLCwas $438k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $716k | n.a. | n.a. |
| Q2 2019 | 1 | $133k | n.a. | n.a. |
| Q3 2019 | 1 | $210k | n.a. | n.a. |
| Q1 2020 | 2 | $5.2m | n.a. | n.a. |
| Q2 2020 | 8 | $51m | n.a. | n.a. |
| Q3 2020 | 4 | $12m | n.a. | n.a. |
| Q4 2020 | 2 | $14m | n.a. | n.a. |
| Q1 2021 | 2 | $48m | n.a. | n.a. |
| Q2 2021 | 2 | $48m | n.a. | n.a. |
| Q3 2021 | 1 | $59m | n.a. | n.a. |
| Q4 2021 | 3 | $81m | n.a. | n.a. |
| Q1 2022 | 1 | $8.3m | n.a. | n.a. |
| Q2 2022 | 1 | $3.8m | n.a. | n.a. |
| Q3 2022 | 1 | $1.5m | n.a. | n.a. |
| Q4 2022 | 2 | $26m | n.a. | n.a. |
| Q1 2023 | 5 | $28m | n.a. | n.a. |
| Q2 2023 | 6 | $69m | n.a. | n.a. |
| Q3 2023 | 2 | $23m | n.a. | n.a. |
| Q4 2023 | 4 | $27m | 2 | 1 |
| Q1 2024 | 5 | $97m | 4 | 1 |
| Q2 2024 | 4 | $95m | 2 | 2 |
| Q3 2024 | 5 | $103m | 4 | 1 |
| Q4 2024 | 4 | $85m | 3 | 1 |
| Q1 2025 | 4 | $64m | 3 | 1 |
| Q2 2025 | 3 | $84m | 2 | 1 |
| Q3 2025 | 4 | $117m | 1 | 3 |
| Q4 2025 | 6 | $265m | 12 | 18 |
| Q1 2026 | 5 | $310m | 18 | 9 |
| Q2 2026 | 5 | $346m | 13 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RCUS and LLY →RCUS and JNJ →RCUS and VRTX →Choose a stock to compare with RCUS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RCUS, latest filings →Back to the 13F Explorer →